LINCOLN ELECTRIC HOLDINGS INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that LINCOLN ELECTRIC HOLDINGS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $3.76B | Feb 21, 2023 |
| FY2022 | Dec 31, 2021 | $3.23B | Feb 21, 2023 |
| FY2022 | Dec 31, 2020 | $2.66B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $3.00B | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $3.03B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $2.62B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $2.27B | Feb 27, 2019 |
| FY2017 | Dec 31, 2015 | $2.54B | Feb 27, 2018 |
| FY2016 | Dec 31, 2014 | $2.81B | Feb 24, 2017 |
| FY2015 | Dec 31, 2013 | $2.85B | Feb 25, 2016 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.23B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $4.01B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $4.19B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $3.76B | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $3.23B | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $2.66B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $3.00B | Feb 18, 2022 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.53B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.47B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $1.47B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $1.28B | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $1.07B | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $871.34M | Feb 21, 2023 |
| FY2019 | Dec 31, 2019 | $240.93M | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | $238.35M | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | $269.88M | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | $258.42M | Feb 27, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $520.53M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $466.11M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $545.25M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $472.22M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $276.58M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $206.12M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $293.11M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $287.07M | Feb 19, 2021 |
| FY2010 | Dec 31, 2010 | $130.24M | Feb 28, 2011 |
| FY2010 | Dec 31, 2009 | $48.58M | Feb 28, 2011 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $718.06M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $636.46M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $717.85M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $612.34M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $461.67M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $282.07M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $370.91M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $375.54M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $376.94M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $283.61M | Feb 27, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $85.55M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $81.82M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $71.24M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $63.21M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $55.97M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $51.41M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $56.85M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $54.17M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $47.90M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $44.72M | Feb 27, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $797.99M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $780.59M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $758.91M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $656.64M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $597.11M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $543.80M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $621.49M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $627.70M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $541.23M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $468.60M | Feb 27, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $661.17M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $598.98M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $667.54M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $383.39M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $365.06M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $351.36M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $403.19M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $329.15M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $334.85M | Feb 27, 2020 |
| FY2010 | Dec 31, 2010 | $156.98M | Feb 28, 2011 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.78B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $3.52B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $3.38B | Feb 26, 2025 |
| FY2024 | Dec 31, 2022 | $3.18B | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $2.59B | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $2.31B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $2.37B | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $2.35B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $2.41B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $1.94B | Feb 27, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.31B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $2.19B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $2.07B | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $2.15B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $1.73B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $1.52B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $1.55B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $1.46B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $1.47B | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $1.23B | Feb 27, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.47B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.33B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $1.31B | Feb 25, 2026 |
| FY2025 | Dec 31, 2022 | $1.03B | Feb 25, 2026 |
| FY2024 | Dec 31, 2021 | $863.91M | Feb 26, 2025 |
| FY2023 | Dec 31, 2020 | $790.25M | Feb 27, 2024 |
| FY2020 | Dec 31, 2019 | $818.17M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $886.94M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $931.64M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $711.48M | Feb 27, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $886.69M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $804.93M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $694.45M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $665.26M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $430.16M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $335.59M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $337.11M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $281.29M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $234.58M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $231.92M | Feb 27, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.34B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $3.99B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $3.69B | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $3.31B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $2.97B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $2.82B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $2.74B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $2.56B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $2.39B | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $2.24B | Feb 27, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $308.79M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $377.26M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $393.79M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $197.15M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $192.96M | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $257.28M | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $199.56M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $358.85M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $326.70M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $379.18M | Feb 27, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $1.10B | Feb 27, 2024 |
| FY2023 | Dec 31, 2022 | $1.12B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $717.86M | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $715.57M | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $712.41M | Feb 19, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 9 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 8 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 9 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 8 | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | 4 | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | 3 | Feb 21, 2023 |
| FY2019 | Dec 31, 2019 | 1 | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | 1 | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | 1 | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | 1 | Feb 27, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 9 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 8 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 9 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 8 | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | 4 | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | 3 | Feb 21, 2023 |
| FY2019 | Dec 31, 2019 | 1 | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | 1 | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | 1 | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | 1 | Feb 27, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 54.85M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 56.21M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | 56.98M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | 57.62M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | 58.79M | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | 59.64M | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | 60.59M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | 63.55M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | 65.66M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | 65.67M | Feb 27, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $168.24M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $162.14M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $148.01M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $130.72M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $121.85M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $118.12M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $117.92M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $102.06M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $92.45M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $87.33M | Feb 27, 2019 |